Information updates


16 March 2020:  

In response to the COVID-19 infectious respiratory disease outbreak caused by the most recently discovered coronavirus, ASCIA has developed a number of resources, including a new open access ASCIA webpage dedicated to COVID-19 information. The situation regarding COVID-19 is rapidly changing so the content of the webpage is regularly reviewed and updated. It includes links to the following information: 

COVID-19 and the ASCIA 2020 Conference | ASCIA COVID-19 FAQ and other Resources | Further Information, News and Publications | COVID-19 and Telehealth

COVID-19 and the ASCIA 2020 Conference

ASCIA is closely monitoring the COVID-19 outbreak in relation to the ASCIA 2020 Conference, scheduled for the first week of September 2020 in Melbourne. Given the rapidly evolving situation in Australia and New Zealand, registrations will be deferred until May 2020 at this stage. ASCIA will take every necessary step to take care of the health and wellbeing of the community, and will continue to provide regular updates as circumstances evolve. If you have any queries, please do not hesitate to contact us. 

ASCIA COVID-19 FAQ and other Resources

ASCIA has developed the following information for patients, which is available on the ASCIA COVID-19 webpage :

  • COVID-19 and Immunodeficiency
  • Checklist: Actions to reduce the spread of COVID-19
  • COVID-19 Frequently asked questions (FAQ)

COVID-19, Immunodeficiency and Immunosuppression 

There is currently limited information available about COVID-19, immunodeficiency and immunosuppression. To expand knowledge in this area and improve patient care, ASCIA is involved in the following initiatives:

  • An ASCIA COVID-19 Working Party will be set up to focus on developing resources for health professionals and the community on COVID-19, immunodeficiency and immunosuppression.
  • ASCIA members will be invited to participate in online webinars, discussion forums and an International Union of Immunological Societies (IUIS) survey on COVID-19, immunodeficiency and immunosuppression.


Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.